Astrazeneca Eu Approval
- All
- News
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
EU Drug Watchdog Approves AstraZeneca's Covid Prevention Jab 'Evusheld'
The EU's drug watchdog on Thursday recommended for approval AstraZeneca's Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines.
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
-
No Ban On Covishield, Request Must For Approval Process: EU Envoy To India
European Union (EU) Ambassador to India Ugo Astuto has clarified there is no ban in the EU on the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University.
-
"Applied For Clearance": Serum Sources On Covishield Issue In EU
The Serum Institute (SII) has applied through AstraZeneca for the European Medicines Agency's nod to get the Covishield vaccine approved for the European Union's 'vaccine passport' scheme, company sources have told NDTV.
-
Not Received Covishield Approval Request, Says EU Medical Body
The European Medicine Agency has not received a request for the approval of Covishield in the COVID-19 'vaccination passport' with the European Union, EU said today.
-
Astrazeneca Files For Vaccine Approval: European Union Medicines Agency
AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the European Union with a decision possible by January 29, The European Medicines Agency said on Tuesday.
-
AstraZeneca Vaccine Approval Unlikely In January: European Union Agency
The coronavirus vaccine developed by AstraZeneca and Oxford University, which was approved Wednesday in Britain, is unlikely to get a green light in the European Union in the next month, according to the European Medicines Agency (EMA).
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
EU Drug Watchdog Approves AstraZeneca's Covid Prevention Jab 'Evusheld'
The EU's drug watchdog on Thursday recommended for approval AstraZeneca's Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines.
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
-
No Ban On Covishield, Request Must For Approval Process: EU Envoy To India
European Union (EU) Ambassador to India Ugo Astuto has clarified there is no ban in the EU on the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University.
-
"Applied For Clearance": Serum Sources On Covishield Issue In EU
The Serum Institute (SII) has applied through AstraZeneca for the European Medicines Agency's nod to get the Covishield vaccine approved for the European Union's 'vaccine passport' scheme, company sources have told NDTV.
-
Not Received Covishield Approval Request, Says EU Medical Body
The European Medicine Agency has not received a request for the approval of Covishield in the COVID-19 'vaccination passport' with the European Union, EU said today.
-
Astrazeneca Files For Vaccine Approval: European Union Medicines Agency
AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the European Union with a decision possible by January 29, The European Medicines Agency said on Tuesday.
-
AstraZeneca Vaccine Approval Unlikely In January: European Union Agency
The coronavirus vaccine developed by AstraZeneca and Oxford University, which was approved Wednesday in Britain, is unlikely to get a green light in the European Union in the next month, according to the European Medicines Agency (EMA).
